A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
94 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- 036-10 - Border Medical Oncology Research Unit
Albury, New South Wales, Australia
- 036-02 - Chris O'Brien Lifehouse
Sydney, New South Wales, Australia
- 036-03 - Westmead Hospital
Sydney, New South Wales, Australia
- 036-09 - Southern Medical Day Care Center
Wollongong, New South Wales, Australia
- 036-04 - Peninsula Health - Frankston Hospital
Frankston, Victoria, Australia
- 036-01 - Western Health - Sunshine Hospital
Melbourne, Victoria, Australia
- 036-05 - Monash Health
Melbourne, Victoria, Australia
- 036-07 - Northern Health - Epping Hospital
Melbourne, Victoria, Australia
- 040-02 - Klinikum Klagenfurt Am Wörthersee
Klagenfurt, Austria
- 040-06 - Ordensklinikum Linz Gmbh - Barmherzige Schwestern
Linz, Austria
- 040-03 - Uniklinikum Salzburg
Salzburg, Austria
- 040-01 - Allgemeines Krankenhaus Der Stadt Wien
Vienna, Austria
- 040-05 - Wilhelminenspital
Vienna, Austria
- 040-04 - Landesklinikum Wiener Neustadt
Wiener Neustadt, Austria
- 124-03 - William Osler Health System - Brampton Civi Hospital
Brampton, Ontario, Canada
- 124-10 - Thunder Bay Regional Health Research Institute
Thunder Bay, Ontario, Canada
- 124-07 - Sunnybrook Research Institute
Toronto, Ontario, Canada
- 124-04 - Cisss de L'Outaouais - Hôpital de Gatineau
Gatineau, Quebec, Canada
- 124-11 - Cisss de Chaudière-Appalaches
Lévis, Quebec, Canada
- 124-01 - Montreal University Health Center
Montreal, Quebec, Canada
- 124-02 - Hôpital de la Cité-de-la-Santé
Laval, Canada
- 124-06 - Jewish General Hospital
Montreal, Canada
- 124-08 - Hôpital Maisonneuve Rosemont
Montreal, Canada
- 124-05 - Ottawa Hospital Research Institute
Ottawa, Canada
- 250-07 - Hôpital Henri Mondor
Créteil, France
- 250-06 - Centre Georges Francois Leclerc
Dijon, France
- 250-01 - Institute Hospitalier Franco-Britannique
Levallois-Perret, France
- 250-09 - Hopital Privé Jean Mermoz
Lyon, France
- 250-08 - Hôpital Européen
Marseille, France
- 250-02 - Hôpital Saint-Antoine
Paris, France
- 250-03 - Hôpital Paris Saint Joseph
Paris, France
- 250-04 - Polyclinique Francheville
Périgueux, France
- 250-05 - Clinique Sainte Anne
Strasbourg, France
- 276-12 - Charité - Universitätsmedizin Berlin
Berlin, Germany
- 276-02 - Universitätsklinikum Carl Gustav Carus
Dresden, Germany
- 276-03 - Krankenhaus Nordwest Gmbh
Frankfurt am Main, Germany
- 276-10 - Universitärers Cancer Center Hamburg (ucch)
Hamburg, Germany
- 276-11 - Klinikum Kassel Gmbh
Kassel, Germany
- 276-04 - Mvz Mitte - Onkologische Schwerpunktpraxis
Leipzig, Germany
- 276-13 - Universitäres Krebszentrum Leipzig (uccl)
Leipzig, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Dec 2018
- Primary completion
- 18 Nov 2022
- Completion
- 18 Nov 2022
- Last update posted
- 26 Oct 2023
- Registered enrollment
- 490
- Registry id
- NCT03750786
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.